Analysis of Cyclin E in Fibrolamellar Hepatocellular Carcinoma by Gustafson, Hannah et al.
Template ID: intuitivecerulean  Size: 48x36
Analysis of Cyclin E in Fibrolamellar Hepatocellular Carcinoma
Katrina Vang, Hannah Gustafson, Sara Stickler, Timothy Vogt
Faculty Advisor: Dr. Mary Ann Yang
Concordia University, Science Department
Fibrolamellar Hepatocellular Carcinoma (FL-HCC) is a rare primary liver cancer affecting 0.02 per 100,000 in the USA (Lalazar & 
Simon 2018). This cancer differs from the most common liver cancer, hepatocellular carcinoma (HCC), due to not being associated 
with any chronic liver diseases, such as cirrhosis or hepatitis (Lim et al., 2014) and occurring commonly in adolescents and young 
adults. Through genomic screening, it’s been found that FL-HCC patients have a heterozygous deletion of approximately 400kb on 
chromosome 19, creating a DNAJB1-PRKACA chimera (Honeyman et al., 2014) as shown in Figure 1. In FL-HCC, there are thick 
fibrous bands in hepatocytes that pathologists use for diagnosis. The only treatment for this aggressive cancer is liver resection, 
with high likeliness of returning. The goal of this research here at CSP, in partnership with Mayo, is to understand the molecular 
cause of this disease so it could help with earlier diagnosis as well as identifying potential drug treatment target(s). 
Background
WESTERN BLOT & DENSITOMETRY 
SDS-PAGE gel electrophoresis is used to separate proteins, followed by western transfer technique to capture proteins on a 
0.45uM nitrocellulose membrane. Once the transfer was completed, nitrocellulose membranes were trimmed and blocked for 1 
hour. Primary antibody concentrations were optimized dilution values for targeted proteins: 1:1,000 (Beta Actin) and 1:250 
(Cyclin E (HE172)). Primary antibody were added overnight. Secondary antibodies, (anti-mouse at 1:2000 or 1:5000 depending 
on which primary antibody used) were added for 1-2.5 hour. Blots were imaged using 0.5mL chemiluminescent substrate and a 
BioRad imager. Isolated protein bands were selected and quantified using ImageJ software for densitometry. 
Results
Conclusion
● There is a difference between the molecular weight of cyclin E detected by same antibody
○ Liver: FL-E (45kDa) & LMW-E (40-35kDa)
○ HEK293: FL-E (65-70kDa) & LMW-E (30kDa)
● The expression level of FL-E vs LMW-E in transfected cells is not consistent with the liver tumor
○ Transfected HEK293 is not behaving like FLHCC. 
■ Potentially FL-E is upregulated first before later being cleaved by NE and that is what was observed in transfected 
HEK293.
● In liver tumor: Less FL-E and more LMW-E
○ Suggesting: FL-E is being cut by NE
● There are more LMW-E present in liver tumor 
○ Possibility that this may be a cause for cancer
● Variation in the expression of FLE or LMW-E between samples  may be due to the different stages in FL-HCC
Future Research
● Perform additional western blotting on FL-HCC human liver samples to get repeatable data of LMW-E. 
● Transfecting a different cell line other than HEK293 with foreign DNA expressing the chimera to test if the chimera plays a role 
in generating LMW-E.
● Repeat the transfection of HEK293 with the addition to proline during cell-proliferation and culturing, specifically working 
towards collagen banding to improve HEK293 as a model of FLHCC tumors. In conjunction with the addition of proline, 
transfecting at different points during cell incubation to recreate stages of the disease. 
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Conclusion and Future Research
Figure 2. Histology of Normal and Tumor Liver Samples: 
(A) Hematoxylin and eosin (H&E) stain of normal liver tissue. (B) H&E stain of FL-HCC liver tissue. (Image 
provided by Dr. Graham from Mayo Clinic). 
A           B
Figure 3. Schematic depicting proteomics data and western blotting of dysregulated enzymes in the proline biosynthetic pathway. 
A) Illustration showing the biochemical pathway with enzymes PYCR, P5CS, OAT and OTC in the context of TCA and Urea cycles and their relationship with proline 
production. Gray arrow indicate process that is unaffected. Black arrow indicate process with catalyzing enzyme upregulated. Dash green arrow indicate process with 
catalyzing enzyme downregulated. B) Western blot analysis of OTC, OAT, P5CS, and PRKACA in normal vs FLHCC samples compared to Beta Actin. 
Hypothesis / Aims:
Figure 1. Schematic of Chromosome 19 
(A) Normal Chromosome (B) Deletion 
endpoint within two coding regions: the 
first exon of DNAJB1 and the trailing nine 
exons of PRKACA (catalytic subunit of 
protein kinase A). (C) Deletion causes 
DNAJB1 and PRKACA gene fusion called a 
chimera. 
Figure 5. Schematic western blot of Cyclin E and LMW-E in normal 
and breast cancer samples. N: normal sample, T: breast tumor 
sample. (Caruso et al., 2018)
SCIENCE
How might the upregulation of proline play a role in the molecular cause of FL-HCC? 
A study done by Oka et al. on rat hepatocytes (normal rat liver cells) found that addition of proline to cultured hepatocytes 
upregulates cyclin E via the mTOR pathway (Oka et al., 2013). Cyclin E is required for the transition from G1/S phase of the cell 
cycle as shown in Figure 4A and it determines the initiation of DNA duplication.  When Oka et al. added rapamycin (an mTOR 
inhibitor) to the hepatocyte culture that contains proline, upregulation of cyclin E was diminished as shown in Figure 4B. The 
mTOR pathway is to regulate protein synthesis and cellular growth either by mTORC1 or mTORC2. In addition, a different study 
found that FL-HCC upregulates mTORC1 signaling because its activity in FL-HCC is significantly greater than that of normal livers 
(Riehle at al., 2015). Indicating there is a dysregulation within the mTORC1 pathway in FL-HCC. However, it is not proven if the 
dysregulation of the mTORC1 have an effect on cyclin E in FL-HCC. 
Figure 4. Schematic of cyclins involved in 
the cell cycle and western blot of cyclin E. 
A) Drawing of the cell cycle and the cyclins 
involved in each stage. Red colored box is 
cyclin E and it helps cells move from G1 
phase to S phase in the cell cycle. B) Western 
blot done by Oka et al. showing addition of 
proline (lane 2) upregulates cyclin E and 
addition of rapamycin stops the 
upregulation. N: non-treated control, P: 
proline, H: HGF, cyc. E1: cyclin E. 
How does Low Molecular Weight Cyclin E (LMW-E) play a role 
in cancer? LMW-E isoforms have been observed in multiple tumor 
types including breast cancer, ovarian cancer, lung cancer, etc.. 
The LMW-E isoform has a weight ranging from 45 to 33 kDa 
compared to 50 kDa in full length-cyclin E (FL-E) as shown in 
Figure 5. LMW-E can be generated through cleaving the FL-E by 
the serine protease neutrophil elastase (NE). One analysis of total 
cyclin E (FL-E + LMW-E) by western blot in patients with breast 
cancer revealed a statistically significant association with distant 
metastases and reduced overall survival (Caruso et al., 2018). This 
study conclude that LMW-E is a oncogenic factor that affect 
cellular functions leading to tumors. 
Histology of FL-HCC: FL-HCC has 
unique histology due to the 
laminated fibrous layers 
intertwined between the tumor 
cells as shown in Figure 2. The 
laminated fibrous are made  of 
collagen which contributes to the 
heavier mass in FL-HCC liver 
compared to a normal. A major 
building block of collagen is 
proline. It contributes to ~17% of 
the collagen formation. 
Proline Involvement in FL-HCC: Our collaborator, Dr. Rolland P. Graham, at the Mayo Clinic, has recently conducted proteomic 
screening (mass spectrometry based analysis) on FL-HCC tumor samples and have identified differential expression in differential 
enzymes involving the proline pathway. Figure 3B depicts the enzymes that are dysregulated in the proline biosynthetic pathway. 
Figure 3A showing the various proline enzymes using western blotting to test Mayo’s findings of the proteomic screening of the 
proline pathway. This was done by past researcher students who were on this project.  
Results
Figure 6. Western blot analysis of transfected HEK293 cells probed with cyclin E antibody (HE172) and beta actin antibody. 
Untransfected lanes are untreated HEK293 cells that contain no foreign DNA. DNAJB1-PRKACA lanes are HEK293 cells transfected with the plasmid DNA containing 
the DNAJB1-PRKACA chimera expressing the chimera protein. DNAJB1-PRKACA GFP lanes are HEK293 cells transfected with the foreign DNA containing the 
DNAJB1-PRKACA chimera fused with GFP. A) HEK293 cells probed with 1° cyclin E (HE172) antibody with a dilution of 1:250 in 1% NFDM and 2° dilution of 1:2000 in 
1% NFDM. Western blot was imaged using the Bio-Rad imager. Red-colored arrow is FL-E with a molecular weight between 45-60 kDa. The yellow-colored arrow is 
LMW-E with a molecular weight between 25-35 kDa. B) HEK293 cells probed with 1° beta actin antibody with a 1:1000 dilution in 1% NFDM and a 2° dilution of 
1:5000 in 1% NFDM. Beta actin have a molecular weight of ~43 kDa. 
Un
tra
ns
fec
ted
Un
tra
ns
fec
ted
DN
AJ
B1
-P
RK
AC
A
DN
AJ
B1
-P
RK
AC
A
DN
AJ
B1
-P
RK
AC
A
GF
P
DN
AJ
B1
-P
RK
AC
A
GF
P
A) HEK293 Cell lysate blotted with cyclin 
E antibody (HE172)
B) HEK293 Cell lysate blotted with 
beta actin antibody
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Figure 8. Western blot analysis of human 
liver samples probed with cyclin E 
(HE172) antibody. Blot probed with cyclin E 
antibody with a 1° dilution of 1:250 in 1% 
NFDM and 2° dilution of 1:2000 in 1% 
NFDM. Western blot was imaged using the 
Bio-Rad imager. “Normal” are samples from 
normal liver biopsies while “tumor” are 
samples from FL-HCC biopsies. Transfected 
are HEK293 cells transfected with foreign 
DNA containing the DNAJB1-PRKACA 
chimera expressing the chimera protein. 
FL-E in liver samples have a molecular 
weight of ~50 kDa. Pink-colored arrow 
indicates the LMW-E band in liver samples 
with a molecular weight between 35-45 kDa. 
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Figure 9. Western blot analysis of human 
liver samples probed with beta actin 
antibody. Blot probed with beta actin 
antibody with a 1° dilution of 1:1000 in 2% 
NFDM and 2° dilution of 1:5000 in 1% 
NFDM. Western blot was imaged using the 
Bio-Rad imager. “Normal” are samples from 
normal liver biopsies while “tumor” are 
samples from FL-HCC biopsies. Beta actin 
has a molecular weight of ~43 kDa. 
Figure 10.  Densitometry based comparison of tumor versus normal samples and statistical analysis of cyclin E expression in liver samples: A series of single 
sided, T-tests to compare two independent sample means were completed to assess if there was a significant difference in sample means. The different t-tests were 
completed for tumor versus normal samples, as denoted on the graph by *,▲, and ●. When looking at FLE presence in the samples, there was a significant difference 
between tumor and normal, with normal samples having a higher mean. When comparing LMW-E, there was a greater average in tumor samples, proven to be 
significantly higher than normal samples. In regards to a final ratio of LMW-E to FLE, adjusted for Beta-Actin, it was found that the ratio was significantly higher in tumor 
samples when compared to normal samples. 
Figure 7. Densitometry based comparison and statistical analysis of cyclin E expression in HEK293 cells: Based off of a one-sided t-test, the differences 
between FL-E of untransfected and transfected were significant. The transfected samples with chimera did not show a significant difference between the 
transfected chimera + GFP, as expected. In regard to LMW-E, the differences between untransfected, transfected and transfected + GFP were significant.
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Hypothesis. Dysregulation of proline 
biosynthetic pathway enzyme by the 
DNAJB1-PRKACA chimera leads to an 
increase of cyclin E expression, which 
is cut by NE creating LMW-E that has 
oncogenic functions, leading to 
tumorigenesis in FL-HCC. 
Aim 1. To test FL-E and LMW-E and 
LMW-E expression in DNAJB1-PRKACA 
transfected HEK293 (human 
embryonic kidney) cells vs 
untransfected cells using western blot 
analysis. 
Aim 2. To test FL-E and LMW-E 
expression in FL-HCC patient liver 
samples vs normal liver samples using 
western blot analysis.
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